National pharmacy associations in the commonwealth: current scenario and future needs to maximise effective contributions of the pharmacy profession towards universal health coverage.
Commonwealth Pharmacy Association
Pharmacy practice
Pharmacy workforce
Sustainable Development Goals
Universal Health Coverage
Journal
Journal of pharmaceutical policy and practice
ISSN: 2052-3211
Titre abrégé: J Pharm Policy Pract
Pays: England
ID NLM: 101627192
Informations de publication
Date de publication:
27 Dec 2021
27 Dec 2021
Historique:
received:
01
07
2021
accepted:
16
12
2021
entrez:
28
12
2021
pubmed:
29
12
2021
medline:
29
12
2021
Statut:
epublish
Résumé
The Commonwealth Pharmacists Association (CPA) is a charity representing pharmacists across the Commonwealth, with the vision of empowering and collaboratively develop the profession and fully utilise the potential of pharmacists to strengthen health systems through supporting better access to, quality and use of medicines and related services. Commonwealth comprises predominantly of low- and middle-income countries, where limited data often exists in pharmacy practice. There is a recognised need across the Commonwealth to focus on developing, implementing and fully utilising pharmacy professional services to progress universal health coverage and achieve the sustainable development goals, particularly in low and middle-income countries; however, currently a knowledge gap exists in understanding the national priorities in Commonwealth nations. CPA is ideally positioned to access to these nations. The aim of this study was thus to explore the priorities and focus areas of NPAs across the Commonwealth and create evidence for a needs-based approach to inform the support that the Commonwealth pharmacists association can collaboratively and strategically provide to its members to progress towards shared goals. Data were collected virtually on Zoom by conducting interviews using a semi-structured interview guide developed for this study with CPA councillors representing NPAs or their equivalents if no official body existed. An inductive, reflexive, thematic analysis was performed for data analysis. In total, 30 councillors were interviewed from 30 low- and medium-income countries. The three main overarching priority areas identified across respective Commonwealth nations developing extended pharmacy services, improving pharmacy education, and developing and redefining the role of NPAs. This novel study highlights the collective priorities for the pharmacy profession across the low and middle-income countries of the Commonwealth and the urgent need for supporting NPAs around the three identified overarching priority areas. The mapped-out priorities will inform an evidence-based approach for the CPA to better support NPAs in their mission through advocacy and practitioner development, to fully harness pharmacists' unique skill set and maximise their contribution to progressing universal health coverage.
Sections du résumé
BACKGROUND
BACKGROUND
The Commonwealth Pharmacists Association (CPA) is a charity representing pharmacists across the Commonwealth, with the vision of empowering and collaboratively develop the profession and fully utilise the potential of pharmacists to strengthen health systems through supporting better access to, quality and use of medicines and related services. Commonwealth comprises predominantly of low- and middle-income countries, where limited data often exists in pharmacy practice. There is a recognised need across the Commonwealth to focus on developing, implementing and fully utilising pharmacy professional services to progress universal health coverage and achieve the sustainable development goals, particularly in low and middle-income countries; however, currently a knowledge gap exists in understanding the national priorities in Commonwealth nations. CPA is ideally positioned to access to these nations. The aim of this study was thus to explore the priorities and focus areas of NPAs across the Commonwealth and create evidence for a needs-based approach to inform the support that the Commonwealth pharmacists association can collaboratively and strategically provide to its members to progress towards shared goals.
METHODS
METHODS
Data were collected virtually on Zoom by conducting interviews using a semi-structured interview guide developed for this study with CPA councillors representing NPAs or their equivalents if no official body existed. An inductive, reflexive, thematic analysis was performed for data analysis.
RESULTS
RESULTS
In total, 30 councillors were interviewed from 30 low- and medium-income countries. The three main overarching priority areas identified across respective Commonwealth nations developing extended pharmacy services, improving pharmacy education, and developing and redefining the role of NPAs.
CONCLUSIONS
CONCLUSIONS
This novel study highlights the collective priorities for the pharmacy profession across the low and middle-income countries of the Commonwealth and the urgent need for supporting NPAs around the three identified overarching priority areas. The mapped-out priorities will inform an evidence-based approach for the CPA to better support NPAs in their mission through advocacy and practitioner development, to fully harness pharmacists' unique skill set and maximise their contribution to progressing universal health coverage.
Identifiants
pubmed: 34961548
doi: 10.1186/s40545-021-00396-7
pii: 10.1186/s40545-021-00396-7
pmc: PMC8710934
doi:
Types de publication
Journal Article
Langues
eng
Pagination
112Informations de copyright
© 2021. The Author(s).
Références
Can Pharm J (Ott). 2018 Dec 25;152(1):45-53
pubmed: 30719197
BMC Health Serv Res. 2014 Aug 27;14:357
pubmed: 25164588
Nat Commun. 2020 Nov 10;11(1):5698
pubmed: 33173055
J Young Pharm. 2011 Oct;3(4):334-42
pubmed: 22224042
Drugs Ther Perspect. 2020;36(8):355-357
pubmed: 32837187
Int J Health Plann Manage. 2014 Apr-Jun;29(2):160-74
pubmed: 23877959
Saudi Pharm J. 2021 Jul;29(7):706-712
pubmed: 34400865
Int J Ment Health Syst. 2010 Jun 15;4:14
pubmed: 20550668
Pharm World Sci. 2007 Feb;29(1):25-33
pubmed: 17268939
Hum Reprod. 2016 Mar;31(3):498-501
pubmed: 26759142
Drugs Aging. 2016 Mar;33(3):213-21
pubmed: 26932714
J Prim Health Care. 2011 Sep 01;3(3):244-7
pubmed: 21892432
Med Care. 2009 Jun;47(6):642-50
pubmed: 19433997
Health Policy. 2012 Jun;106(1):37-49
pubmed: 22265340
J Pharm Policy Pract. 2020 May 13;13:13
pubmed: 32426144
Res Social Adm Pharm. 2021 Jan;17(1):1799-1806
pubmed: 33317760
J Pharm Policy Pract. 2015 Feb 10;8(1):4
pubmed: 25815199
Lancet Glob Health. 2020 Jun;8(6):e754-e755
pubmed: 32278364
J Am Pharm Assoc (Wash). 2003 Mar-Apr;43(2):136-9
pubmed: 12688431
Health Soc Care Community. 2018 Mar;26(2):e249-e260
pubmed: 28990292
J Pharm Policy Pract. 2021 Jan 6;14(1):6
pubmed: 33407945
Res Social Adm Pharm. 2019 Jul;15(7):815-817
pubmed: 30846369
Health Policy Plan. 2019 Dec 1;34(Supplement_3):iii1-iii3
pubmed: 31816069
Future Hosp J. 2014 Oct;1(2):80-83
pubmed: 31098053
Health Policy Plan. 2004 Jul;19(4):234-41
pubmed: 15208279
Am J Health Syst Pharm. 2008 Mar 1;65(5):462-7
pubmed: 18281740
J Health Organ Manag. 2017 May 15;31(3):270-285
pubmed: 28686135
J Pain Palliat Care Pharmacother. 2012 Dec;26(4):310-25
pubmed: 23216170
J Pharm Policy Pract. 2019 Sep 18;12:25
pubmed: 31548892
J Educ Health Promot. 2021 Mar 31;10:113
pubmed: 34084860
Res Social Adm Pharm. 2020 Aug;16(8):1131-1135
pubmed: 31864887
Integr Pharm Res Pract. 2017 Jan 25;6:37-46
pubmed: 29354549
Global Health. 2018 Nov 1;14(1):102
pubmed: 30382856
Am J Pharm Educ. 2010 Dec 15;74(10):S7
pubmed: 21436916
BMJ. 2007 Oct 20;335(7624):803-5
pubmed: 17947785
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
Bull World Health Organ. 2013 Nov 1;91(11):892-4
pubmed: 24347720
Sci Transl Med. 2013 Aug 21;5(199):199ed13
pubmed: 23966297
Res Social Adm Pharm. 2021 Jan;17(1):1964-1966
pubmed: 32317154
Lancet. 2015 Feb 7;385(9967):549-62
pubmed: 25468153
South Med Rev. 2012 Dec;5(2):3-8
pubmed: 23535994
Pharmacy (Basel). 2020 Mar 26;8(2):
pubmed: 32224904
J Pharm Policy Pract. 2020 May 26;13:10
pubmed: 32509311